Search

everythinglearnresearchcommunity

for

Search:↓

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

People with no symptoms or mild COVID-19 have lower antibody levels, increasing their risk of getting COVID-19 again.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

COVID-19 vaccination may trigger lupus in some people.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Possible link between androgens and COVID-19 severity; more research needed.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

No single biomarker is reliable enough for diagnosing and assessing SLE.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The research found that different types of fibroblasts are involved in wound healing and that some blood cells can turn into fat cells during this process.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.